NCT01507038View on ClinicalTrials.gov

Safety and Efficacy of YH14617 in Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Diabetes Mellitus
Interventions
DRUG

YH14617

1mg once weekly

DRUG

YH14617

1.6mg once weekly

DRUG

YH14617

2mg once biweekly

DRUG

Placebo

Once weekly

Trial Locations (1)

Unknown

Yuhan, Seoul

Sponsors

Collaborators (1)

Peptron, Inc.
All Listed Sponsors
collaborator

Peptron, Inc.

INDUSTRY

lead

Yuhan Corporation

INDUSTRY

NCT01507038 - Safety and Efficacy of YH14617 in Diabetes Mellitus | Biotech Hunter | Biotech Hunter